Germany plans coronavirus vaccine development EU alliance: report | News | DW | 04.06.2020
  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages
Advertisement

News

Germany plans coronavirus vaccine development EU alliance: report

Wary of US and Chinese efforts to secure large doses of potential COVID-19 vaccines, Germany is working with three EU states on a vaccine procurement plan. The UK is set to host a global summit on vaccine development.

Germany is set to forge a new alliance with three European Union countries to secure access to coronavirus vaccines, once they are developed, German newspaper Handelsblatt reported Thursday.

Health Minister Jens Spahn wrote to the European Commission along with his counterparts from France, Italy and the Netherlands to announce that they have joined to "achieve the fastest and best possible outcome in negotiations with key players in the pharmaceutical industry."

The four EU countries have identified the development of a vaccine as "one of the most urgent issues that the European Union has to address at present."

Germany is eager to ensure the EU will have vaccine access over fears that China or the United States may attempt to control purchases of any potential vaccines.

The US has already secured almost a third of the first 1 billion doses planned for pharmaceutical company AstraZeneca experimental vaccine by pledging $1.2 billion (€1.07 billion). AstraZeneca is one of several companies that Germany is now in talks with, according to Handelsblatt.

The four EU countries may be in talks with other non-EU members on working together for vaccine procurement, including Singapore, the UK and Japan.

The EU is also preparing to use a €2.4 billion ($2.7 billion) fund to make advance purchases of vaccines, Reuters news agency reported. The use of the emergency fund is yet to be officially announced.

Read more: EU seeks pharma loopholes to make vaccines more accessible

Watch video 02:20

Covid breakthroughs drive German biotech boom

EU pledges €300 million to global vaccine summit

UK Prime Minister Boris Johnson planned to host a summit on vaccine development with international leaders later on Thursday. He is expected to attempt to raise at least $7.4 billion primarily to help the world's poorest nations in vaccine procurement.

Johnson called the so-called Vaccine Alliance Gavi summit a "new era of global health cooperation."

Ahead of the summit, the European Union announced they will pledge €300 million to Gavi.

One of the key aims is to provide vaccines for at least 300 million children at a vastly reduced cost.

Around 50 world leaders are expected to attend the virtual summit, as well as individual philanthropists like Microsoft founder and billionaire Bill Gates. Russia’s President Vladimir Putin declined an invitation to attend, although Russia has the third-highest number of cases in the world.

ed/aw (dpa, Reuters)

Watch video 02:30

Vaccine efforts a mix of competition and cooperation

Each evening at 1830 UTC, DW's editors send out a selection of the day's hard news and quality feature journalism. You can sign up to receive it directly here.

DW recommends